<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CLARITHROMYCIN</span><br/>(clar'i-thro-my-sin)<br/><span class="topboxtradename">Biaxin Filmtabs, </span><span class="topboxtradename">Biaxin XL<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">macrolide antibiotic</span><br/><b>Prototype: </b>Erythromycin<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>250 mg, 500 mg tablets; 500 mg sustained-release tablets; 125 mg/5 mL, 250 mg/5 mL suspension</p>
<h1><a name="action">Actions</a></h1>
<p>A semisynthetic macrolide antibiotic that binds to the 50S ribosomal subunit of susceptible bacterial organisms and thus inhibits
         protein synthesis of the bacteria.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>It is active against both aerobic and anaerobic gram-positive and gram-negative organisms including <i>Streptococcus pyogenes, S. pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Mycoplasma pneumoniae,</i> and <i>Staphylococcus aureus</i>.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Treatment of upper respiratory, lower respiratory infections; acute maxillary sinusitis; otitis media; and skin and soft tissue
         infections caused by clinically significant aerobic and anaerobic gram-negative and gram-positive organisms, including <i>S. aureus, H. influenzae, S. pneumoniae, M. catarrhalis, S. pyogenes, M. pneumoniae.</i> Prevention and treatment of <i>Mycobacterium avium complex</i> (MAC) infections in patients with HIV. Used in combination for <i>Helicobacter pylori.</i>
</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to clarithromycin, erythromycin, or any other macrolide antibiotics; patients receiving pimozide; suspected
         or potential bacteremias; acute porphyria; severe hepatic or biliary disease; pregnancy (category C). Safety and efficacy
         in children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Renal impairment, older adults, and lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Mild to Moderate Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 250500 mg b.i.d. or 500 mg XL q.d. for 1014 d<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 7.5 mg/kg q12h<br/><br/><span class="indicationtitle">Mycobacterial Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 500 mg q12h<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 7.5 mg/kg q12h<br/><br/><span class="indicationtitle">
<i>H. pylori</i> Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 500 mg b.i.d. to t.i.d.<br/><br/><span class="impairmenttitle">Renal Impairment</span><br/>Cl<sub>cr</sub> <br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Ensure that sustained-release form of drug is not chewed or crushed. It must be swallowed whole.</li>
<li>Shake suspension well before use.</li>
<li>Store at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> GI:</span> Diarrhea, abdominal discomfort, nausea, abnormal taste, dyspepsia. <span class="typehead">Hematologic:</span>  Eosinophilia. <span class="typehead"> CNS:</span> Headache. <span class="typehead">Skin:</span> Rash, urticaria. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>May increase serum AST and ALT levels.</p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>  May increase <b>theophylline</b> levels; drugs known to interact with <b>erythromycin</b> (i.e., <b>digoxin,</b>
<b>carbamazepine,</b>
<b>triazolam,</b>
<b>warfarin,</b>
<b>ergotamine,</b>
<b>dihydroergotamine</b>) should be monitored carefully for increased levels and toxicity; <b>pimozide</b> may increase risk of arrhythmias. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract; 50% reaches the systemic circulation. <span class="typehead"> Peak:</span> 24 h.  <span class="typehead">Distribution:</span> Widely distributes into most body tissue (excluding CNS); high pulmonary tissue concentrations. <span class="typehead">Metabolism:</span> Partially metabolized in the liver; active 14-OH metabolite acts synergistically with the parent compound against <i>H. influenzae.</i>
<span class="typehead">Elimination:</span> 20% excreted unchanged in urine; 1015% of 14-OH metabolite excreted in urine. <span class="typehead">Half-Life:</span> 35 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Inquire about previous hypersensitivity to other macrolides (e.g., erythromycin) before treatment.</li>
<li>Withhold drug and notify physician, if hypersensitivity occurs (e.g., rash, urticaria).</li>
<li>Monitor for and report loose stools or diarrhea, since pseudomembranous colitis must be ruled out.</li>
<li>When clarithromycin is given concurrently with anticoagulants, digoxin, or theophylline, blood levels of these drugs may be
            elevated. Monitor appropriate serum levels and assess for S&amp;S of drug toxicity.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Complete prescribed course of therapy.</li>
<li>Report rash or other signs of hypersensitivity immediately.</li>
<li>Report loose stools or diarrhea even after completion of drug therapy.</li>
<li>Do not breast feed without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>